MICROPROFITBIO

Microprofit Biotech, as a national high-tech enterprise, consistently pays much attention to manufacture, R&D, marketing and sales of in vitro diagnosis (IVD) products. The official brand of Microprofit Biotech, fluorecare, has dedicated to entire products of point-of-care (POC) tests based on immunofluorescence quantitative assay platform, which are applied to monitor and prognosis of human diseases with comprehensive parameters, including tumor markers, hormone markers, cardiac markers, infection markers and diabetes markers... Microprofit fluorecare Immunofluorescence Quantitative Platform uses immunochromatographic technology, aiming for the diagnosis of common human diseases. Based on specific antigen-antibody reaction, the triggered fluorescence of the fluorochrome-labeled complexes is collected and automatically calculated. For certain analyte, including serum, plasma, urine or other sample, fluorecare is able to measure the concentration of various biological markers including..

Primary location: Shenzhen China